Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-05-12 @ 12:38 AM
Study NCT ID:
NCT05000294
Status:
SUSPENDED
Last Update Posted:
2025-10-15
First Post:
2021-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Sponsor:
University of Florida
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UF-STO-ETG-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None